Figure 5
Figure 5. Down-regulation of apoptosis in early splenic erythroblasts in ERK1−/− mice. (A) Changes in Fas (n = 6 ERK1+/+, n = 7 ERK1−/−; left) and FasL (n = 10 ERK1+/+, n = 11 ERK1−/−; right) cell-surface expression on splenic erythroblasts from ERK1−/− mice and ERK1+/+ mice. The results are expressed as percentages of Fas/FasL-positive cells within each erythroblast subset. (B) Annexin V expression on splenic erythroblasts from ERK1-deficient mice (n = 6) compared with ERK1+/+ mice (n = 6). The results are expressed as percentages of annexin V–positive cells within each erythroblast subset. Data are means ± SEMs (*P < .05; **P < .01)

Down-regulation of apoptosis in early splenic erythroblasts in ERK1−/− mice. (A) Changes in Fas (n = 6 ERK1+/+, n = 7 ERK1−/−; left) and FasL (n = 10 ERK1+/+, n = 11 ERK1−/−; right) cell-surface expression on splenic erythroblasts from ERK1−/− mice and ERK1+/+ mice. The results are expressed as percentages of Fas/FasL-positive cells within each erythroblast subset. (B) Annexin V expression on splenic erythroblasts from ERK1-deficient mice (n = 6) compared with ERK1+/+ mice (n = 6). The results are expressed as percentages of annexin V–positive cells within each erythroblast subset. Data are means ± SEMs (*P < .05; **P < .01)

Close Modal

or Create an Account

Close Modal
Close Modal